SynBioBeta·4 min read·hard
Hedging on Hype
✦AI Summary
Four major pharmaceutical rivals—Pfizer, AstraZeneca, Merck, and Teva—formed a joint venture called AION Labs in 2020 to explore AI applications in drug discovery. The collaboration allowed these competitors to share the high costs and risks associated with testing emerging AI technologies.
How Four Pharma Rivals Used One Venture Studio to Test-Drive Every AI Trend of the Decade
businessscienceai
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in